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Reduced glomerular filtration, hypertension and renal microvascular injury are hallmarks
of chronic kidney disease, which has a global prevalence of ∼10%. We have shown
previously that the Fischer (F344) rat has lower GFR than the Lewis rat, and is more
susceptible to renal injury induced by hypertension. In the early stages this injury is
limited to the pre-glomerular vasculature. We hypothesized that poor renal hemodynamic
function and vulnerability to vascular injury are causally linked and genetically determined.
In the present study, normotensive F344 rats had a blunted pressure diuresis relationship,
compared with Lewis rats. A kidney microarray was then interrogated using the Endeavour
enrichment tool to rank candidate genes for impaired blood pressure control. Two
novel candidate genes, P2rx7 and P2rx4, were identified, having a 7- and 3- fold
increased expression in F344 rats. Immunohistochemistry localized P2X4 and P2X7
receptor expression to the endothelium of the pre-glomerular vasculature. Expression
of both receptors was also found in the renal tubule; however there was no difference
in expression profile between strains. Brilliant Blue G (BBG), a relatively selective P2X7
antagonist suitable for use in vivo, was administered to both rat strains. In Lewis rats,
BBG had no effect on blood pressure, but increased renal vascular resistance, consistent
with inhibition of some basal vasodilatory tone. In F344 rats BBG caused a significant
reduction in blood pressure and a decrease in renal vascular resistance, suggesting
that P2X7 receptor activation may enhance vasoconstrictor tone in this rat strain. BBG
also reduced the pressure diuresis threshold in F344 rats, but did not alter its slope.
These preliminary findings suggest a physiological and potential pathophysiological role
for P2X7 in controlling renal and/or systemic vascular function, which could in turn affect
susceptibility to hypertension-related kidney damage.
Keywords: purinergic, ATP, kidney disease, renal injury, renal vascular resistance
INTRODUCTION
Kidney injury and declining renal function are diagnostic indi-
cators of kidney disease and present a global health burden with
high population prevalence (Eckardt et al., 2013). Genetic, epi-
genetic and environmental factors determine susceptibility to
renal injury and the development of chronic kidney disease.
Hypertension is a major risk factor for kidney disease (Nakayama
et al., 2011) and progression can be slowed if blood pres-
sure is controlled (Hart and Bakris, 2010). Nevertheless, renal
injury and fibrosis develop independently of barotrauma and the
local actions of agents such as aldosterone (Ashek et al., 2012;
Kawarazaki et al., 2012) and angiotensin II (Mori and Cowley,
2004; Polichnowski et al., 2011) have been implicated.
We have previously used the Cyp1a1-Ren2 transgenic rat to
investigate pathways leading to renal injury. In these rats, blood
pressure is increased by dietary administration of the non-toxic
aryl hydrocarbon, indole-3-carbinol (Kantachuvesiri et al., 2001).
The rise in blood pressure can be titrated to study the organ
injury associated with slowly developing (Conway et al., 2012)
or malignant hypertension (Kantachuvesiri et al., 2001). In the
malignant setting, vascular injury predominates, with myocycte
vacuolation preceding confluent myocyte cell death and microal-
buminuria (Ashek et al., 2012).
Genetic background influences susceptibility to renal injury
in several rat models (Churchill et al., 1997; Schulz and Kreutz,
2012), the Cyp1a1-Ren2 transgenic rat being no exception
(Kantachuvesiri et al., 2001). Here, the Fischer (F344) strain is
susceptible while Cyp1a1-Ren2 transgenic rats on the Lewis back-
ground are protected from renal injury. We have used these
informative strains to identify Quantitative Trait Loci for organ
injury (Kantachuvesiri et al., 1999) and the development of recip-
rocal congenic lines enabled us to validate Ace, the gene encoding
Angiotensin Converting Enzyme, as a plausible modifier of renal
injury (Liu et al., 2009). Although the angiotensin receptor antag-
onist losartan prevents the blood pressure rise in this model, it
is only partially protective against renal vascular injury (Ashek
et al., 2012). This suggests that susceptibility to renal injury
in this model is governed by the interplay between multiple
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pathways. We hypothesized that genes differentially expressed
in the Cyp1a1-Ren2 transgenic rat in the normotensive state
would contain candidates contributing to poor renal function
and susceptibility to renal injury in the F344 strain or the relative
renoprotection observed on the Lewis background.
In the present study we compared the pressure diuresis rela-
tionship between the differentially susceptible F344 and Lewis
rats. This response being blunted in F344 animals, we re-mined
a renal exon-microarray (Liu et al., 2009) identifying the genes
encoding the P2X4 receptor and P2X7 receptor as candidates for
altered vascular function in F344 rats.
MATERIALS AND METHODS
MICROARRAY ANALYSIS
A previously published Affymetrix microarray (Liu et al., 2009)
was re-mined to identify differentially expressed probe-sets in
the kidney of normotensive Cyp1a1-Ren2 transgenic rats, i.e.,
rats in which the Ren2 transgene was silent. The array was
performed on four groups of rats (n = 4 per group): the two
consomic parental strains (F344, Lewis) and the two recip-
rocal congenic strains (F344-MOD-Lewis, Lewis-MOD-F344)
containing a 14Mb region of chromosome 10. This con-
genic region contained the Ace locus and the congenics were
included in the present analysis to determine whether cis (or
trans) regulation occurred. The 16CEL intensity files were
imported into Bioconductor and arrays normalized by the
Robust Multi-array Average (RMA) method. The Linear Models
for Microarray Data (LIMMA) algorithm was used to calcu-
late fold-change and p-value statistics from the normalized
intensities.
Differentially expressed genes were imported into the web
client online version of the multi-database enrichment tool
Endeavour (Aerts et al., 2006, 2009). A list of 157 “training”
genes isolated from the rat genome database (Laulederkind
et al., 2002) was also imported. The “training” genes used
in this study were selected for their association with blood
pressure regulation in the rat. They were not tissue specific
and assumed no mutual exclusivity with inflammatory, or
other disease, processes. The Endeavour method then employed
multiple database mining using parallel approaches to enrich
the list of differentially regulated genes. These approaches
were: (i) published literature text mining; (ii) protein-protein
interactions in the STRING database; (iii) transcriptome anal-
ysis from the WalkerEtAl database; (iv) sequence compari-
son with BLAST; and (v) annotations within Gene Ontology,
InterPro, KEGG, and Swiss-Prot. Finally, global ranking by
Q-statistic generated a list of genes in order of prioritiza-
tion for the observed phenotype, known as “genomic data
fusion.”
ANIMALS
Experiments were performed on male F344 and Lewis rats
(Charles River, UK). All rats had access to food and water (Special
Diet Services, Witham, Essex, UK) ad libitum. Procedures were
performed in accordance with the UK Home Office Animals
(Scientific Procedures) Act of 1986 after ethical review by The
University of Edinburgh.
For Western analysis and immunohistochemistry, F344 and
Lewis rats (n = 3 per genotype) were killed by decapitation. The
kidneys were rapidly excised and the left kidney was snap frozen
and stored at −80C for subsequent extraction of total protein.
The right kidney was immersion fixed in 10% buffered formalin,
transferring to 70% ethanol after 48 h. These kidneys were then
paraffin embedded and transverse sections taken for IHC.
IMMUNOHISTOCHEMISTRY
Primary rabbit polyclonal antibodies against the P2X1 (APR-
001, Alomone Labs), P2X4 (APR-002, Alomone Labs), and
P2X7 (APR-004, Alomone Labs) receptors were selected based
on published validation for use in the rat. Each antibody
was then optimized in a dilution series (1:250, 500, 1000,
2000, 4000, 5000, and 7500) using control rat kidney, fol-
lowing heat-induced epitope recovery (HIER) with citrate
buffer. The final titers were selected to give minimal back-
ground: P2X1 (1:5000), P2X4 (1:7500), and P2X7 (1:2000).
All staining was performed on a Leica Bond × immunos-
taining robot using a refined HRP polymer detection system.
Briefly, after HIER and blocking in Peroxidase, the section was
incubated in primary antibody for 2 h at room temperature.
Following two 5min washes, sections were exposed to anti-rabbit
HRP polymer before being washed. Immunopositive staining
was visualized with 3,3′-diaminobenzidine and counterstaining
with hematoxylin.
WESTERN BLOT
Whole kidneys were homogenized in ice-cold buffer con-
taining 250mmol/l sucrose and 10mmol/l triethanolamine.
Protease inhibitors (Cocktail set III, Calbiochem) and phos-
phatase/kinase inhibitors (2mmol/l EDTA, 50mmol/l NaF,
25mmol/l sodium glycerophosphate, 5mmol/l pyrophosphate,
and 1mmol/l sodium orthovanadate) were added and the pH
adjusted to 7.6. Following quantification by Bradford assay, pro-
tein samples were added to Laemlli buffer and resolved by SDS-
PAGE, on a NuPAGE Tris-Acetate gel (8% NovexTM) using a
Tris-acetate running buffer (50mmol/l tricine, 50mmol/l Tris
base, 0.1% SDS, pH 8.24) NuPAGE antioxidant was added to the
upper chamber. For the P2X4 studies, 12µg of total protein was
loaded; 20µg for P2X7 receptor experiments. Following semi-
dry transfer the membrane was incubated overnight at 4C with
the primary antibody (P2X4 1:2000; P2X7 1:1000; Alomone as
described above). A goat-antirabbit HRP secondary antibody was
then added and the bands visualized by ECL. The P2X4 anti-
body detected a band of ∼60 kDa; the P2X7 antibody detect a
band at ∼75 kDa. The autoradiogram was scanned and band
intensity (corrected for background) was quantified by den-
sitometry using ImageJ. Values were normalized to the total
protein intensity (Coomasie-Blue) at the appropriate molecular
weight.
RENAL FUNCTIONAL STUDIES
Rats were anaesthetized (Thiobutabarbital 120mg/kg IP) and
prepared surgically for measurement of the pressure-diuresis rela-
tionship. The right jugular vein was cannulated and 0.9% NaCl
was infused at a rate of 50µl/min/100 g during abdominal surgery
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(to replace surgical losses) and then at 33µl/min/100 g during the
post-surgical equilibration (60min) and throughout the exper-
imental protocol. The left femoral artery was cannulated and
connected to brass transducer (MLT844; Capto) connected to a
Powerlab (AD Instruments, UK). Blood pressure was recorded
continuously at 1 kHz. A midline laparotomy was performed and
a Doppler transit time probe (MA1PRB; Transonic, USA) placed
around the left renal artery. Acoustic gel was used to ensure good
sonic coupling. Loose silk ties were placed around the superior
mesenteric and coeliac arteries: these ligatures were tightened
during the experimental procedure to create an acute pressure
ramp of two stages above baseline blood pressure. The bladder
was catheterized for urine collection under mineral oil with flow
rate being determined gravimetrically. The entire procedure was
performed under homeostatic temperature control at 37◦C.
Pressure-diuresis experiments were performed first on a con-
trol group of F344 (n = 7) and Lewis (n = 5) rats and then on
a second cohort of F344 (n = 5) and Lewis (n = 6) rats receiv-
ing an IV infusion (50µg/min/100 g) of Brilliant Blue G (BBG,
Sigma, UK).
STATISTICAL ANALYSIS
Data are presented as mean ± s.e.m. or as individual data with
median. Statistical analysis was performed by Mann-Whitney
U-test (for Western analysis) or by unpaired t-test (physiologi-
cal data). Comparisons between groups of the pressure-diuresis
relationship were made by linear regression.
RESULTS
PRESSURE DIURESIS RELATIONSHIP
Compared to Lewis rats, F344 rats had a higher baseline blood
pressure (Figure 1A) and a lower renal blood flow (Figure 1B):
renal vascular resistance was significantly higher in F344 rats
than in Lewis (Figure 1C). The imposition of a pressure ramp
evoked an increase in urine flow rate in both strains of rats
(Figure 2A). The slope of the relationship was significantly dif-
ferent from zero in both groups (P < 0.001) but was blunted in
the F344 strain compared to the Lewis (P < 0.01). There was no
significant relationship between blood flow and blood pressure
in either strain of animals, indicative of intact auto-regulation
(Figure 2B).
RENAL MICROARRAY ANALYSIS
After normalization, 67 probe-sets were differentially regulated
on the basis of genetic background: 23 over-expressed and 44
under-expressed (Table 1). Endeavour analysis was used to rank
the differentially expressed genes enriched against the training
genes of blood pressure regulation. The ten highest globally
ranked genes are given in Table 2. Ace was the highest ranked
gene, consistent with our previous QTL and congenic studies
(Liu et al., 2009), and was not studied further. The 2nd and 3rd
ranked genes were P2rx7 and P2rx4, respectively. The expres-
sion of both was higher in the F344 rats than in the Lewis
rats. This was confirmed by Western analysis: there was a 7-fold
increase in total P2X7 receptor protein (P < 0.05; Figure 3A)
and a 3-fold increase in P2X4 receptor abundance (P < 0.05;
Figure 3B).
FIGURE 1 | (A) Mean arterial blood pressure; (B) left renal artery blood flow
and (C) renal vascular resistance in the left renal artery measured in Lewis
(n = 8; open bars) and F344 (n = 7; black bars) rats. Data are mean ± SE.
Statistical comparisons were made with unpaired t-test. ∗∗∗P < 0.001;
∗∗P < 0.01.
FIGURE 2 | (A) Pressure diuresis and (B) pressure flow relationship in
Lewis (n = 8; open squares) and F344 (n = 7; black squares) rats. Data are
mean ± SE. Statistical test was performed by linear regression analysis.
RENAL LOCALIZATION OF P2X1,4, and 7 RECEPTORS
We observed no differences between strains in the distribu-
tion of immunostaining for the P2X receptors. Renal vascular
P2X4 immuno-positive staining was restricted to the endothelium
throughout the preglomerular vasculature (Figure 4A). P2X4
receptor staining was observed in the renal tubules of both strains.
In some places this staining was punctate and localized to both the
nucleus and cytoplasm (Figure 4B).
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Table 1 | Genome wide comparison of gene expression between F344
and Lewis inbred strains listed in order of magnitude of fold change
(F344 vs. Lewis, fold > ± 1.2, p < 0.05).
Over expressed genes (+) Under expressed genes (−)
Symbol Fold p-value Symbol Fold p-value
Rpl30 +7.6798 0.0226 Olr1668 −27.2451 0.0123
Akr1c2 +7.3466 0.0241 Olr1680 −24.6268 0.0162
Spta1 +5.6906 0.0090 RGD1309362 −13.1217 0.0162
Akr1b8 +4.6613 0.0178 Pigzl1 −6.7012 0.007
LOC361914 +3.6785 0.0094 Kif5c −6.6248 0.009
Ace +3.5400 0.0178 Ces1e −5.7903 0.0094
LOC100359585 +3.3860 0.0250 Cyp4v3 −5.2337 0.0166
Guca2b +2.7994 0.0479 Olr1326 −5.1722 0.0336
Ypel4 +2.7596 0.0253 Acsm5 −4.7035 0.0178
Rtp4 +2.6916 0.0241 Hhip −4.6118 0.0166
Clstn2 +2.5879 0.0253 Hmgcs2 −4.2039 0.0336
P2rx4 +2.5327 0.0162 Cyp2d5 −3.8624 0.0289
Klkb1 +2.4303 0.0090 Rdh2 −3.4214 0.0162
Exnef +2.4073 0.0090 LOC302192 −3.3622 0.0256
Pigr +2.3473 0.0336 Lcn2 −3.097 0.0253
P2rx7 +2.1586 0.0336 Csmd1 −3.019 0.0336
Akr1b7 +2.1071 0.0336 Slc10a2 −2.7769 0.0226
Cd59 +1.8540 0.0256 Rxrg −2.6987 0.0336
Fam149a +1.7008 0.0336 Cntnap4 −2.6686 0.0192
P4ha2 +1.6668 0.0336 RT1-CE5 −2.6679 0.0336
Arl4d +1.5187 0.0336 Erc2 −2.5297 0.0253
Igfbp4 +1.4873 0.0336 Ptprq −2.4522 0.0182
Col15a1 +1.2734 0.0336 RGD1311723 −2.4244 0.0372
Rbp4 −2.3816 0.0336
Abcb10 −2.2669 0.0256
Sult1b1 −2.2336 0.0493
RGD1563120 −2.1689 0.045
Mis18a −2.1532 0.0192
Slc35f1 −2.1291 0.0372
Tcerg1l −2.0443 0.0253
Acadsb −1.9181 0.0336
Rgs7 −1.8925 0.0277
Retsat −1.8721 0.0253
Gas2 −1.8114 0.045
Ly75 −1.74 0.0442
Slco1a6 −1.7194 0.031
Slc26a11 −1.6736 0.0317
Pfas −1.6633 0.0178
Eps8l2 −1.6505 0.0336
Dpp6 −1.6382 0.0259
RGD1311575 −1.5914 0.0491
RGD1564614 −1.5199 0.0344
Cdc42ep2 −1.4477 0.0372
Synm −1.4011 0.0442
Genes identified by enrichment analysis (Table 2) shown in bold font.
Vascular P2X7 receptor staining was observed in the endothe-
lium of the pre-glomerular arteries, including the afferent arteri-
oles of both rat strains (Figures 4B,C). Staining was also observed
in the glomerulus (Figure 4C). In the larger arteries, occasional
expression in the vascular smooth muscle was observed but in
a given vessel this was limited to a small number of myocytes
(Figure 4D).
As shown by the low magnification image, P2X1 receptor
expression was limited to the vascular network and not expressed
in the renal tubules (Figure 4E). P2X1 receptor immuno-
positive staining was observed in the smooth muscle layer of
all artery types from lobar to afferent arteriole in both rat
strains.
EFFECT OF INFUSION OF BRILLIANT BLUE G
Under baseline (non-ligated) conditions, acute infusion of BBG
caused a significant reduction of mean arterial blood pressure
in F344 rats but not in Lewis animals (Figure 5A). Blood flow
through the left renal artery was not significantly affected by BBG
in either group (Figure 5B). However, BBG caused a significant
decrease in renal vascular resistance in F344 rats (Figures 5C, 6B).
Acute infusion of BBG did not affect the pressure-diuresis rela-
tionship in Lewis rats (Figure 6A). In F344 rats, BBG caused
a significant leftward shift of the pressure-diuresis intercept
(Figure 6B), reducing the threshold of this response, but did not
alter the gradient of the slope. There was no significant relation-
ship between blood flow and blood pressure in either strain (data
not shown).
DISCUSSION
F344 rats are susceptible to renal vascular injury whereas Lewis
rats are relatively protected (Liu et al., 2009). We find that
normotensive F344 rats have a blunted pressure diuresis rela-
tionship, which would impair blood pressure control and may
underpin the susceptibility to vascular injury observed in this
strain. At a genetic level, we identified increased renal expres-
sion of P2X4 and P2X7 receptors, which may contribute to
impaired vascular function in F344 rats, compared to the Lewis
strain.
Multiple subtypes of P2X and P2Y receptors are expressed
throughout the kidney and extracellular nucleotides regulate
renal tubular, endocrine, and vascular functions (Bailey and
Shirley, 2009; Bailey et al., 2012; Shirley et al., 2013). Purinergic
control of renal vascular tone is complex and the net vasoactive
effect depends upon the route of administration/physiological
source of the extracellular nucleotide. Thus, ATP applied in vitro
to the adventitial surface of the renal microvasculature causes
contraction (Inscho et al., 1992) mediated by P2X1 receptors
(Inscho et al., 2003) in the vascular smooth muscle (Chan
et al., 1998). In contrast, infusion of ATP into the renal artery
increases blood flow (Tagawa and Vander, 1970) and the vasodi-
latation is dependent on production of nitric oxide/prostacyclin
by the endothelium (Eltze and Ullrich, 1996). The P2 recep-
tor subtype(s) that mediate the vasodilatory response to ATP
is not resolved and may vary in different vascular beds. mRNA
encoding P2Y1, P2Y2, P2X4, and P2X7 receptors have all been
identified in human arterial endothelial cells (Yamamoto et al.,
2000; Ray et al., 2002). P2X4 receptors are the most abun-
dantly expressed, followed by P2X7 (∼50%) and then by P2Y1
and P2Y2 (∼20%) receptors (Yamamoto et al., 2000). A sim-
ilar profile is observed in endothelial cells cultured from the
mouse pulmonary artery (Yamamoto et al., 2006) and P2X4 and
Frontiers in Physiology | Renal and Epithelial Physiology October 2013 | Volume 4 | Article 305 | 4
Menzies et al. Renal vascular P2X4 and P2X7 receptors
Table 2 | Global prioritization by the Endeavour enrichment method.
Gene Known biological function(s) Global prioritization
Rank Score Rank ratio
Ace (ENSRNOG00000007467) BP regulation 1 0.0187 0.0909
P2rx7 (ENSRNOG00000001296) Ion transport, cell volume, apoptosis 2 0.0624 0.182
P2rx4 (ENSRNOG00000001300) Ion transport, BP regulation, NOS 3 0.118 0.273
Rgs7 (ENSRNOG00000021984) G-protein signaling 4 0.583 0.364
Erc2 (ENSRNOG00000015148) Nerve terminal assembly 5 0.674 0.455
Klkb1 (ENSRNOG00000014118) Proteolysis, coagulation, inflammation 6 0.787 0.545
Kif5c (ENSRNOG00000004680) Motor axon guidance 7 0.796 0.636
Dpp6 (ENSRNOG00000030547) Proteolysis 8 0.933 0.727
Pigr (ENSRNOG00000004405) Antibody receptor 9 0.936 0.818
Rdh2 (ENSRNOG00000029651) Retinoid metabolism, oxidation reduction 10 0.988 0.909
FIGURE 3 | Western blot analysis of (A) P2X7 receptor and (B) P2X4 receptor expression in whole kidney homogenates. The top panels show the blot
performed in Lewis and F344 rats (n = 3 in each). The bottom panels show the blot intensity (normalized to protein loading) quantified by densitometry.
P2X7 receptors have also been immunolocalized to the endothe-
lium of the larger renal arteries of the rat (Lewis and Evans,
2001).
Our studies are largely consistent with this distribution of
P2X receptors. P2X1 receptor expression was limited to the vas-
cular smooth muscle of the renal arteries and afferent arteriole.
Renal autoregulation is severely attenuated in P2X1 null mice,
(Inscho et al., 2004; Guan et al., 2007; Inscho, 2009), illus-
trating the importance of this receptor for renal vascular func-
tion. In the present study, renal autoregulation was intact in
both strain of rats and we find no evidence linking differen-
tial expression of the P2X1 receptor, or indeed P2X4 or P2X7
receptors to the impaired renal vascular function observed in
F344 rats.
We did find increased abundance of P2X4 and P2X7 recep-
tor, both in the microarray analysis and at the protein level.
In humans the encoding genes, P2RX4 and P2RX7, are located
within 130 kb of each other on chromosome 12. These genes
can be regulated independently: the endothelial expression of
P2X4 receptors in the human aorta is increased following injury;
P2X7 receptor expression is not affected (Pulvirenti et al., 2000).
It is possible, however, that these receptors have common pro-
motor elements. Physiological interactions between the receptors
are postulated (Craigie et al., 2013) and the locus is associated
with human disease. For example, a single nucleotide polymor-
phism (SNP) in the first intron of P2RX7 is strongly associ-
ated with elevated blood pressure (Palomino-Doza et al., 2008)
and a loss-of-function SNP in the P2RX7 coding region asso-
ciates with protection against ischemic stroke (Gidlöf et al.,
2012). Similarly, a loss of function SNP in the P2X4 receptor
has been associated with increased pulse pressure (Stokes et al.,
2011).
Consistent with the previous studies described, we localized
P2X4 and P2X7 receptors to the endothelium of the pre-
glomerular vasculature. Our bioinformatic ranking analysis asso-
ciated increased expression with vascular dysfunction and loss
of blood pressure control. Both P2X4 (Yamamoto et al., 2006)
and P2X7 receptors (Liu et al., 2004) can modulate blood
vessel contractility by promoting the release of vasodilators
from the endothelium. One interpretation of our data is that
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FIGURE 4 | (A) Vascular P2X4 receptors were expressed in the
endothelium (Image from F344 rat ×400) and (B) the afferent arteriole
(Image Lewis rat ×500). (C) P2X7 receptors were stained in the
endothelium of the preglomerular vasculature, including the afferent
arteriole (arrow) and cells of the glomerulus (Image F344 rat, ×400). (D)
Occasional smooth muscle staining of P2X7 was observed (arrow; Lewis
rat, ×400). (E) P2X1 immunopositive staining was only observed in the
vasculature and was limited to the smooth muscle layer of large and small
diameter vessels (F344 rat, ×50).
the up-regulation of receptors in F344 rats is a compensatory
response to improve poor renal blood flow. Thus, acute recep-
tor antagonism in vivo should inhibit this tonic vasodilation.
There was a trend for this in the Lewis rats but the reduction in
blood flow induced by BBG was not statistically different. BBG
did induce a significant hemodynamic effect in F344 rats but
this was to increase blood flow, rather than to reduce it. One
interpretation of this outcome is that in F344 rats P2X4/P2X7
receptor activation induces a tonic vasoconstriction. It is difficult
to reconcile such an effect with the predominantly endothe-
lial location of these receptors. However, the endothelium also
releases potent vasoconstrictive mediators, including mono- or
di-nucleoside polyphosphates such as adenosine 5′ tetraphos-
phate (Tolle et al., 2008) and uridine adenosine tetraphosphate
is a partial agonist at the rat P2X4 receptor (Wildman et al.,
1999) and causes a profound vasoconstriction when perfused via
the intravascular route into the isolated rat kidney (Tolle et al.,
2008).
An obvious concern in interpreting these results is the selectiv-
ity of the antagonist, BBG. This compound is a potent inhibitor
of rat P2X7 receptors (IC50 = 10 nM) and although it can also
block the P2X4 receptor, its selectivity for P2X7 receptor is
FIGURE 5 | (A)Mean arterial blood pressure; (B) left renal artery blood flow
and (C) renal vascular resistance in the left renal arterymeasured in Lewis and
F344 rats receiving either saline or Brilliant Blue G by intravenous infusion.
Data are mean ± SE. Statistical comparisons were made within strain by
unpaired t-test. ∗∗∗P < 0.001; ∗P < 0.05. Statistical comparisons were made
using one way ANOVA with Bonferroni post-test.
FIGURE 6 | The Pressure diuresis relationship measured in (A) Lewis
and (B) F344 rats receiving either saline (closed symbols) or Brilliant
Blue G (open symbols) by intravenous infusion. Data are mean ± SE.
Statistical test was performed by linear regression analysis.
1000-fold greater. BBG has been used previously in vivo to elu-
cidate P2X7 receptor functionality (Jiang et al., 2000; Peng et al.,
2009). Indeed, chronic administration of BBG reduces renal
injury and lowers blood pressure in the Dahl salt sensitive rat
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(Ji et al., 2012a); P2X7 null mice are similarly protected from
the renal injury associated with salt-induced hypertension (Ji
et al., 2012b). Nevertheless, BBG may also antagonize rat P2X4
receptors and our infusion protocol could inhibit both P2X
receptor subtypes. Furthermore, a number of off-target effects
of BBG have been reported (Katrahalli et al., 2010), so we can-
not exclude the possibility that P2X7-independent effects also
contribute to the hemodynamic actions of BBG observed in the
F344 rats.
P2X4 and P2X7 receptors were also identified in the renal
tubule in both strains of rats. Tubular expression of P2X4 recep-
tor is consistent with several previous studies (Bailey et al.,
2012). We found some evidence of intracellular, punctate stain-
ing, particularly in the Lewis rats. It is possible that this rep-
resents expression of P2X4 receptors in intracellular vesicles,
which might act as a reservoir for trafficking of receptors to the
apical or basolateral membrane or serve as mediators of vac-
uolar calcium release (Sivaramakrishnan and Fountain, 2012).
P2X receptors, including P2X4 can regulate tubular sodium
reabsorption processes (Bailey et al., 2012) but in our studies
BBG did not affect urine flow rate. The relationship between
P2X4 receptor activation and sodium/water reabsorption is com-
plex, however, and may depend on the local sodium concentra-
tion.
In summary, P2X7 and P2X4 receptors are expressed in the
vascular endothelium and may contribute to the normal control
of renal arterial resistance. Both receptors are attractive candi-
date genes for impaired renal vascular function and susceptibility
to kidney injury. However, their respective roles are not easy to
define: the present findings are consistent with a predominant
vasoconstrictor effect of P2X7 and vasodilator effect of P2X4,
but the relationship is likely to be more complex than this sim-
ple dichotomy suggests. For example, endothelial P2X7 receptors
can mediate the release of factors that modulate the inflamma-
tory state of the vessel wall (Wilson et al., 2007). Moreover, the
encoding gene for P2X7 transcribes a large number of splice vari-
ants with reportedly different functionality (Sluyter and Stokes,
2011; Xu et al., 2012), which may also contribute to contrast-
ing vasoactive effects in different strains of rat as observed
here.
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